Predicting clinical progression in multiple sclerosis after 6 and 12 years
Iris Dekker(Amsterdam Neuroscience), Menno M. Schoonheim(Amsterdam Neuroscience), Veronica Popescu(Hasselt University), A. J. C. Eijlers(Amsterdam Neuroscience), Lisanne J. Balk(Amsterdam UMC Location Vrije Universiteit Amsterdam), Mike P. Wattjes(Humboldt-Universität zu Berlin), Frederik Barkhof(Netherlands Institute for Neuroscience), Hugo Vrenken(Amsterdam Neuroscience), Bernard M.J. Uitdehaag(Amsterdam UMC Location Vrije Universiteit Amsterdam), Joep Killestein(Amsterdam UMC Location Vrije Universiteit Amsterdam), Jeroen J.G. Geurts(Amsterdam Neuroscience)
Cited by 58
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
|Multiple Sclerosis Journal|2020|2.5k